Keywords: genvac, gets, fda, fast, track, tnferade, drug

GenVac gets FDA Fast Track for TNFerade

Article | 17 November 2008

Print This

US drug developer GenVec has been granted Fast Track designation for TNFerade for the treatment of locally-advanced pancreatic cancer by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in